Shares of HCA Holdings, Inc. (NYSE:HCA) have been assigned an average rating of “Buy” from the nineteen analysts that are currently covering the firm, MarketBeat reports. One analyst has rated the stock with a sell recommendation, five have issued a hold recommendation and thirteen have issued a buy recommendation on the company. The average 1-year price target among analysts that have issued ratings on the stock in the last year is $92.33.

A number of brokerages have issued reports on HCA. Zacks Investment Research downgraded HCA Holdings from a “buy” rating to a “hold” rating in a report on Tuesday, March 28th. Cantor Fitzgerald reissued a “buy” rating and issued a $95.00 price target on shares of HCA Holdings in a report on Monday, April 17th. Deutsche Bank AG began coverage on HCA Holdings in a report on Tuesday, April 4th. They issued a “buy” rating and a $103.00 price target for the company. Mizuho raised HCA Holdings from a “neutral” rating to a “buy” rating and set a $98.00 price target for the company in a report on Monday, March 27th. Finally, Argus began coverage on HCA Holdings in a report on Wednesday, June 28th. They issued a “buy” rating and a $100.00 price target for the company.

In related news, SVP Jana Joustra Davis sold 54,689 shares of the stock in a transaction on Tuesday, May 23rd. The stock was sold at an average price of $82.35, for a total value of $4,503,639.15. Following the completion of the transaction, the senior vice president now directly owns 107,892 shares of the company’s stock, valued at approximately $8,884,906.20. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, SVP Robert A. Waterman sold 246,000 shares of the stock in a transaction on Friday, May 5th. The shares were sold at an average price of $83.12, for a total value of $20,447,520.00. Following the completion of the transaction, the senior vice president now directly owns 392,252 shares of the company’s stock, valued at $32,603,986.24. The disclosure for this sale can be found here. Over the last three months, insiders sold 397,424 shares of company stock valued at $33,234,810. 2.90% of the stock is owned by corporate insiders.

A number of hedge funds have recently modified their holdings of the stock. BlackRock Inc. boosted its stake in shares of HCA Holdings by 2,549.4% in the first quarter. BlackRock Inc. now owns 20,099,811 shares of the company’s stock valued at $1,788,682,000 after buying an additional 19,341,168 shares during the last quarter. FMR LLC boosted its stake in shares of HCA Holdings by 15.8% in the first quarter. FMR LLC now owns 7,763,884 shares of the company’s stock valued at $690,908,000 after buying an additional 1,059,925 shares during the last quarter. Old Mutual Global Investors UK Ltd. boosted its stake in shares of HCA Holdings by 44.6% in the first quarter. Old Mutual Global Investors UK Ltd. now owns 1,627,311 shares of the company’s stock valued at $144,814,000 after buying an additional 501,591 shares during the last quarter. Morgan Stanley boosted its stake in shares of HCA Holdings by 51.7% in the first quarter. Morgan Stanley now owns 1,186,998 shares of the company’s stock valued at $105,630,000 after buying an additional 404,599 shares during the last quarter. Finally, Vanguard Group Inc. boosted its stake in shares of HCA Holdings by 1.9% in the first quarter. Vanguard Group Inc. now owns 19,576,992 shares of the company’s stock valued at $1,742,157,000 after buying an additional 361,027 shares during the last quarter. Institutional investors own 74.49% of the company’s stock.

TRADEMARK VIOLATION NOTICE: This story was published by American Banking News and is the sole property of of American Banking News. If you are viewing this story on another domain, it was illegally copied and reposted in violation of United States and international copyright and trademark laws. The original version of this story can be accessed at https://www.americanbankingnews.com/2017/07/21/hca-holdings-inc-hca-given-average-recommendation-of-buy-by-brokerages.html.

HCA Holdings (NYSE HCA) traded down 0.48% during midday trading on Friday, reaching $85.35. 1,277,915 shares of the company’s stock were exchanged. HCA Holdings has a 52 week low of $67.00 and a 52 week high of $91.03. The firm has a market capitalization of $31.32 billion, a price-to-earnings ratio of 11.60 and a beta of 0.69. The firm’s 50 day moving average is $85.22 and its 200 day moving average is $84.21.

HCA Holdings (NYSE:HCA) last announced its quarterly earnings results on Tuesday, May 2nd. The company reported $1.74 earnings per share (EPS) for the quarter, meeting the Zacks’ consensus estimate of $1.74. HCA Holdings had a negative return on equity of 45.28% and a net margin of 6.70%. The company had revenue of $10.62 billion during the quarter, compared to the consensus estimate of $10.64 billion. During the same period in the previous year, the company posted $1.71 earnings per share. HCA Holdings’s revenue for the quarter was up 3.5% on a year-over-year basis. On average, equities analysts anticipate that HCA Holdings will post $7.36 earnings per share for the current year.

About HCA Holdings

HCA Healthcare, Inc, formerly HCA Holdings, Inc, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.

Analyst Recommendations for HCA Holdings (NYSE:HCA)

Receive News & Ratings for HCA Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.